Department of Neurosurgery, University of Texas McGovern Medical School, Houston, Texas, USA.
Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
J Neurointerv Surg. 2023 Jul;15(7):717-722. doi: 10.1136/jnis-2022-018732. Epub 2022 Sep 9.
Carotid artery stenosis is a leading cause of ischemic stroke. While management of symptomatic carotid stenosis is well established, the optimal approach in asymptomatic carotid artery stenosis (aCAS) remains controversial. The rapid evolution of medical therapies within the time frame of existing landmark aCAS surgical revascularization trials has rendered their findings outdated. In this review, we sought to summarize the controversies in the management of aCAS by providing the most up-to-date medical and surgical evidence. Subsequently, we compile the evidence surrounding high-risk clinical and imaging features that might identify higher-risk lesions. With this, we aim to provide a practical framework for a precision medicine approach to the management of aCAS.
颈动脉狭窄是缺血性脑卒中的主要原因。虽然症状性颈动脉狭窄的治疗方法已经成熟,但无症状性颈动脉狭窄(aCAS)的最佳治疗方法仍存在争议。在现有的无症状颈动脉狭窄外科血运重建试验的时间框架内,医学治疗方法的快速发展使得这些研究结果已经过时。在这篇综述中,我们旨在通过提供最新的医学和外科证据,总结无症状颈动脉狭窄治疗中的争议。随后,我们收集了与高危临床和影像学特征相关的证据,这些特征可能有助于识别更高危的病变。通过这些,我们旨在为无症状颈动脉狭窄的精准医疗方法提供一个实用的框架。